BI 3776528

· Boehringer Ingelheim

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for BI 3776528, covering 2025-11-21 to 2025-11-21. Get the full timeline:

Most recent: Clinical Trial Update: A Study in Healthy Men to Test How Well Different Doses of BI 3776528 Are Tolerated [Phase 1]